Loading...
Medication therapy for opioid use disorder (OUD) has been demonstrated to mitigate withdrawal symptoms, reduce relapses and overdoses, and save lives. However, emergency department (ED) initiation of buprenorphine treatment for OUD remains underutilized. To assess drivers of underutilization, researchers surveyed clinicians and conducted focus groups at four academic urban EDs.
Among 258 respondents, only 20.9% felt ready to prescribe buprenorphine and only 3.5% had completed training to do so. The primary perceived barriers to initiation of buprenorphine in the ED were lack of training and experience, concern about availability of outpatient follow-up, the busy ED environment with multiple competing priorities, and the DEA X-waiver. Perceiv…